Correlation Between PolyPid and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PolyPid and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PolyPid and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PolyPid and Fennec Pharmaceuticals, you can compare the effects of market volatilities on PolyPid and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PolyPid with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PolyPid and Fennec Pharmaceuticals.
Diversification Opportunities for PolyPid and Fennec Pharmaceuticals
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between PolyPid and Fennec is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and PolyPid is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PolyPid are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of PolyPid i.e., PolyPid and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between PolyPid and Fennec Pharmaceuticals
Given the investment horizon of 90 days PolyPid is expected to generate 5.51 times less return on investment than Fennec Pharmaceuticals. But when comparing it to its historical volatility, PolyPid is 1.89 times less risky than Fennec Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Fennec Pharmaceuticals is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 458.00 in Fennec Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of 74.00 from holding Fennec Pharmaceuticals or generate 16.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PolyPid vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| PolyPid |
| Fennec Pharmaceuticals |
PolyPid and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PolyPid and Fennec Pharmaceuticals
The main advantage of trading using opposite PolyPid and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PolyPid position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.The idea behind PolyPid and Fennec Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Fennec Pharmaceuticals vs. Eliem Therapeutics | Fennec Pharmaceuticals vs. HCW Biologics | Fennec Pharmaceuticals vs. RenovoRx | Fennec Pharmaceuticals vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |